论文部分内容阅读
采用建德市肾综合征出血热Ⅰ型灭活疫苗效果考核现场资料，计算５～９岁和１０～１４岁各年龄组的效益费用比（ＢＣＲ）和效果费用比（ＣＥＲ）。结果各年龄组ＢＣＲ和ＣＥＲ均小于１或大于０；５～９岁年龄组儿童接种疫苗后的ＣＥＲ和预防一个病人的费用是１０～１４岁年龄组的一倍左右。结论：可在高发区１０～１４岁儿童中开展ＨＦＲＳ疫苗预防接种。
The data of effectiveness test of type I inactivated vaccine against type 2 HSVH in Jiande City were used to calculate the benefit cost ratio (BCR) and effect cost ratio (CER) for 5 ~ 9 years old and 10 ~ 14 years old groups. Results The BCR and CER in all age groups were less than 1 or greater than 0. The costs of vaccinating children 5-9 years old with CERs and preventing one patient were about twice as much as those in the 10-14-year age group. Conclusion: HFRS vaccination can be carried out in children aged 10-14 years in high incidence areas.